Jonah Flynn is an Atlanta, Georgia based Reglan lawyer handling personal injury claims associated with the drug Reglan and its generic equivalents.
In February, the FDA informed the medical community that manufacturers of metoclopramide, a drug used to remedy gastrointestinal disorders, would be required to add a warning to their drug labels about the potential dangers of its long-term or high-dose treatment.
The label advises customers that use of metoclopramide has been linked to tardive dyskinesia, which may cause a variety of involuntary movements, speech issues, and tremors even after a patient is no longer taking the drug.
These issues are rarely reversible and there is no known treatment.
Metoclopramide is available in a several forms and the names include some version of Reglan or the actual word, metoclopramide. More than 2 million people in this country are taking some form of the drug, according to FDA estimates.
Reglan manufacturers including Wyeth, a successor-in-interest to A.H. Robins, Inc., and American Home Products Corporation, and Schwarz Pharma, Inc. Generic manufacturers of metoclopramide including Teva Pharmaceuticals and Actavis Elizabeth.